Advanced Practice Midwife in Santa Clara, CA Accepting Medicare

1 Advanced Practice Midwife nurses found. Showing 1 - 1

Lisa Marie Vincenti, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 700 Lawrence Expy Dept 300, Santa Clara, CA 95051 Phone: 650-345-3863

News Archive

Diagnosing Infections Through Molecules in Patient Breath

Over the past couple of decades, the analytical technology and the clinical microbiology insight needed to create a breath test for infections has seen a considerable number of advances and there are now numerous research teams focused on evaluating patient breath as a diagnostic fluid for infectious diseases. Significant challenges still need to be overcome.

Experts warn doctors to be aware of new requirements in health bill's false claims act

"A longtime Miami-Dade healthcare operator and his son have been charged with bilking more than $2.8 million from Medicare in an undercover FBI case. The father has fled the country and the son is cooperating with authorities. Ernesto Angel Montaner and his son, Ernesto Montaner, are accused of operating a network of physical rehabilitation clinics in Miami-Dade that submitted millions of dollars in phony bills to the federal healthcare program for the elderly and disabled between 2003 and 2008" (Weaver, 4/24).

Tweaking gene in satellite cells may increase lifespan of people with muscular dystrophy

Researchers have long questioned why patients with Duchenne muscular dystrophy (DMD) tend to manage well through childhood and adolescence, yet succumb to their disease in early adulthood, or why elderly people who lose muscle strength following bed rest find it difficult or impossible to regain.

NovaDigm announces data from NDV-3 vaccine Phase 1 study on Candida and Staph infections

NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced the publication of data from its first-in-human Phase 1 study of its NDV-3 vaccine program in the journal Vaccine.

PlasmaTech Biopharmaceuticals closes underwritten public offering of common stock

PlasmaTech Biopharmaceuticals, Inc., a biopharmaceutical company advancing patient care in critical areas, announced the closing of an underwritten public offering of 3,500,000 shares of common stock, and warrants to purchase up to an aggregate 3,500,000 shares of common stock, at an offering price of $4.00 per share and $.01 per warrant.

Read more Medical News

› Verified 4 days ago